Ameet Mallik
Chief Executive Officer chez ADC THERAPEUTICS SA
Fortune : 3 M $ au 31/03/2024
Provenance du réseau au premier degré de Ameet Mallik
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 24 | |
Public Company | Pharmaceuticals: Major | 21 | |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Public Company | Real Estate Development | 9 | |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria.
6
| Subsidiary | Pharmaceuticals: Generic | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ameet Mallik via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Private Equity Investor Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
IMMUNOGEN, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
IMMUNOMEDICS, INC. | Biotechnology | Compliance Officer Director/Board Member | |
INCYTE CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Private Equity Investor Chief Tech/Sci/R&D Officer | |
PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Human Resources Officer | |
SEAGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Public Communications Contact | |
TRANSGENE | Biotechnology | Director/Board Member Chief Executive Officer | |
HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel President | |
ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer | |
University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree | |
NOVARTIS AG | Pharmaceuticals: Major | Compliance Officer Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Stanford University | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
STADA ARZNEIMITTEL | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer | |
MORPHOSYS AG | Biotechnology | Corporate Officer/Principal President | |
Boston University | College/University | Undergraduate Degree Doctorate Degree | |
MACROGENICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
University of Cambridge | College/University | Corporate Officer/Principal Graduate Degree | |
Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Undergraduate Degree | |
New York University | College/University | Graduate Degree Undergraduate Degree | |
St. Mary's College of California | College/University | Masters Business Admin Undergraduate Degree | |
INSEAD | College/University | Masters Business Admin Graduate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
University of California, Davis | College/University | Corporate Officer/Principal Undergraduate Degree | |
University of Connecticut | College/University | Undergraduate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer | |
University of the Witwatersrand | College/University | Doctorate Degree Doctorate Degree | |
PDL BIOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer General Counsel | |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The private company is based in Basel, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
Auven Therapeutics Management LLLP
Auven Therapeutics Management LLLP Investment ManagersFinance Founded in 2007 by Stephen Evans-Freke and Peter Corr, Auven Therapeutics Management LLLP is a global private equity firm located in St. Thomas, Virgin Islands. They also have operations in New York City and Europe. The firm was formerly known as Celtic Therapeutics Management, which was the successor firm to Celtic Pharma Management LP. | Investment Managers | Founder Private Equity Investor | |
Auven Therapeutics Holdings LP
Auven Therapeutics Holdings LP Investment ManagersFinance Auven Therapeutics Holdings LP invests in late stage companies developing therapeutic products (small-molecules & biologics) and related diagnostics. It provides financing for buyouts and late stage capital requirements. It makes controlling investments. | Investment Managers | Founder Chief Executive Officer | |
ADC Products (UK) Ltd.
ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom. | Medical/Nursing Services | Founder Director/Board Member Director/Board Member | |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Benjamin N. Cardozo School of Law | College/University | Graduate Degree Graduate Degree | |
AVADEL PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
Spirogen SARL
Spirogen SARL Pharmaceuticals: MajorHealth Technology Spirogen SARL is a Swiss company. 'The private company is based in Lausanne, Switzerland. The company was founded by Christopher John Martin. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member |
Statistiques
Internationale
Etats-Unis | 35 |
Suisse | 5 |
Royaume-Uni | 4 |
Allemagne | 4 |
France | 3 |
Sectorielle
Health Technology | 31 |
Consumer Services | 15 |
Finance | 4 |
Health Services | 3 |
Retail Trade | 2 |
Opérationnelle
Director/Board Member | 277 |
Corporate Officer/Principal | 173 |
Independent Dir/Board Member | 101 |
Undergraduate Degree | 53 |
Chief Tech/Sci/R&D Officer | 47 |
Relations les plus connectées
Insiders | |
---|---|
Beth Seidenberg | 39 |
Carol Gallagher | 39 |
Stephen Evans-Freke | 34 |
Jean Bizzari | 24 |
Ronald Renaud | 24 |
Jacques Theurillat | 22 |
Viviane Monges | 21 |
Shannon Klinger | 19 |
Michael Forer | 18 |
Christopher Martin | 18 |
Vasant Narasimhan | 17 |
William Heiden | 17 |
Matthew Fust | 16 |
Mark McCamish | 15 |
Tyrell J. Rivers | 15 |
- Bourse
- Insiders
- Ameet Mallik
- Connexions Sociétés